Preclinical characterization of UCB0022, an oral, brain penetrant, selective, clinical-stage positive allosteric modulator of the dopamine 1 receptor (D1 PAM) C. Vermeiren, A. Ates, F. Bouzom, A. Delaunois,M. Gillard,B. Kenda, A. Ousset,L. Provins, D. Skolc, A. Valade, M. Vanmeulder, M. Wood,Y. LambertyMOVEMENT DISORDERS（2022）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
